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Escherichia coli K1 is the most common cause of 
meningitis in premature infants (46%), whereas 
it is the second most common agent in full-
term  neonates  (15%;  Bonacorsi  and  Bingen, 
2005; Shah et al., 2005). Mortality rates of 5% 
are  recorded  in  children  in  the  developed 
world, but these rise to 30% in developing 
countries (Bedford et al., 2001; Houdouin et al., 
2008). Despite recent advances in antibiotic 
therapy  and  supportive  care,  bacterial  sepsis 
and meningitis caused by E. coli remain a seri-
ous disease (Mulder et al., 1984; de Louvois 
et al., 1991). Although the mortality rates can 
be reduced by antibiotic treatment, the neuro-
logical sequelae in 30–40% of the survivors lead 
to mental retardation, hearing loss, and other 
complications (Kim, 2003). Ventriculitis fre-
quently accompanies neonatal meningitis, par-
ticularly when caused by E. coli K1, Enterobacter 
sakazakii, and other Gram-negative organisms 
(Jones et al., 2004). A recent surge in antibiotic-
resistant strains of E. coli K1 may significantly 
increase the mortality and morbidity rates (Boyer-
Mariotte et al., 2008; Dubois et al., 2009). In ad-
dition, the prognosis of meningitis is difficult 
until the bacteria reach the cerebrospinal fluid 
(CSF), by which time greater amounts of proin-
flammatory cytokines are circulating in the blood 
and the progression of brain damage has begun. 
Treatment with antibiotics during high bacter-
emia releases significant amounts of endotoxin, 
which often causes septic shock and, ultimately, 
organ dysfunction. Therefore, alternative ave-
nues to treat and prevent this deadly disease 
are needed.
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Ineffectiveness of antibiotics in treating neonatal Escherichia coli K1 meningitis and the 
emergence of antibiotic-resistant strains evidently warrants new prevention strategies.  
We observed that administration of interleukin (IL)-10 during high-grade bacteremia clears 
antibiotic-sensitive and -resistant E. coli from blood of infected mice. Micro-CT studies of 
brains from infected animals displayed gross morphological changes similar to those  
observed in infected human neonates. In mice, IL-10, but not antibiotic or anti-TNF  
antibody treatment prevented brain damage caused by E. coli. IL-10 administration  
elevated CR3 expression in neutrophils and macrophages of infected mice, whereas infected 
and untreated mice displayed increased expression of FcRI and TLR2. Neutrophils or 
macrophages pretreated with IL-10 ex vivo exhibited a significantly greater microbicidal 
activity against E. coli compared with cells isolated from wild-type or IL-10/ mice.  
The protective effect of IL-10 was abrogated when CR3 was knocked-down in vivo by siRNA. 
The increased expression of CR3 in phagocytes was caused by inhibition of prostaglandin  
E-2 (PGE-2) levels, which were significantly increased in neutrophils and macrophages 
upon E. coli infection. These findings describe a novel modality of IL-10–mediated E. coli 
clearance by diverting the entry of bacteria via CR3 and preventing PGE-2 formation in 
neonatal meningitis.
© 2010 Mittal et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it  is  available  under  a  Creative  Commons  License  (Attribution–Noncommer-
cial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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RESULTS
IL-10 is required for host survival, pathogen control,  
and prevention of hyperinflammatory immune response  
in neonatal E. coli K1 meningitis
To investigate the role of IL-10, 3-d-old WT and IL-10/ 
mice were infected intranasally with 103 CFU of E. coli K1 
and various parameters of the resulting infection and disease 
were compared. Analysis of serum samples at various time 
points revealed that IL-10 production peaked around 12 h 
after infection, whereas peak production of TNF, IFN-, 
IL-1, IL-12, and IL-6 was observed at 72 h after infection 
in WT mice (Fig. 1, A and B, and Fig. S1, A–D). In contrast, 
these proinflammatory cytokines were observed in signifi-
cantly higher quantities by 24 h after infection in IL-10/ 
mice (P < 0.01 compared with WT animals; Fig. 1 B and 
Fig. S1, A–D). A high level of bacteremia (106 CFU of bac-
teria) was observed in WT animals starting from 48 h, whereas 
IL-10/ mice showed similar bacteremia levels by 12 h after 
infection (Fig. 1 C). The WT animals developed meningitis 
as demonstrated by positive CSF cultures, between 72 and 96 h 
after infection, whereas IL-10/ mice showed the patho-
gens in CSF by 16 h. IL-10/ animals succumbed to infec-
tion within 48 h even at an inoculum size of 102 CFU of 
E. coli (unpublished data). Histopathological examination of 
the brains at 72 h (WT) and 24 h (IL-10/) after infection 
indicated that the pathological conditions in this model are 
very similar to that of humans. Spotty neuronal necrosis and 
scattered apoptotic bodies were seen both in the cortex and 
hippocampal dentate gyrus in the brain of E. coli K1–infected 
mice compared with control uninfected animals (Fig. 1 D). 
Acute inflammation in the brain and spreading along pene-
trating vessels into the cerebral cortex and white matter was 
prominent. A high number of neutrophils was observed at 
the base of the brain involving leptomeninges, cisternal areas, 
and choroidal fissures. Increase in cellularity was conspicuous 
in the molecular layer of cerebral cortex. Acute hemorrhage 
in the choroid plexus was also observed. These pathological 
changes were much more pronounced in the brains of IL-10/ 
mice compared with WT animals. On par with these results, 
the tissue damage markers lactate dehydrogenase and malondi-
aldehyde (MDA) were increased dramatically in brains of 
IL-10/–infected animals in comparison to WT-infected 
mice, whereas glutathione levels decreased, indicating oxida-
tive stress (Fig. S1, E–G). Quantification of the influx of various 
cells into brain tissue showed a moderate influx of microglia, 
granulocytes, B cells, and macrophages in WT mice, which 
was even more prominent in IL-10/ mice (Fig. 1, E–H). 
In contrast, the influx of CD4+ and CD8+ T cells were similar 
up to 24 h after infection in both these animals (Fig. S2,   
A and B). IL-10 production in brain also robustly increased by 
12 h after infection and declined by 72 h, which correlated 
with IL-10 mRNA, as RT-PCR showed high amounts of 
IL-10 transcripts in infected animals compared with control 
uninfected mice (Fig. S2, C–E). These results suggest that 
IL-10 plays a vital role in controlling the inflammatory re-
sponse during the acute phase; however, the production of 
A certain threshold of bacteremia is required for the ad-
herence of E. coli to the cerebrovascular endothelium and for 
subsequent crossing of the blood–brain barrier (Xie et al., 
2004), indicating that the bacterium in circulation must evade 
host defense mechanisms. Complement and phagocytes are 
responsible for the clearance of bacterial pathogens at early 
stages of infection (van Lookeren Campagne et al., 2007). 
Our studies demonstrated that E. coli K1 avoids complement 
attack by binding to C4b-binding protein, a modulator of the 
classical complement pathway via outer membrane protein A 
(Prasadarao et al., 2002; Wooster et al., 2006; Maruvada et al., 
2008). Neutrophils and macrophages form an important line 
of defense against invading pathogens and phagocytose patho-
gens through a variety of surface receptors, especially FcRI 
and CR3 (Isberg and Tran Van Nhieu, 1994; Aderem and 
Underhill, 1999; McCoy and O’Neill, 2008). Neutrophils 
often increase in number during sepsis, a stage preceding 
meningitis, and represent an important source of proinflam-
matory cytokines (Pinheiro da Silva and Soriano, 2009). 
Neutrophils are programmed to undergo constitutive apo-
ptosis in the absence of prosurvival stimuli in keeping with 
their short-lifespan (Kennedy and DeLeo, 2009). Critically, 
apoptotic cells also serve as a source of antigen for antigen-
presenting DCs. However, E. coli K1 also interacts with DCs 
to suppress both maturation and antigen presentation (Mittal 
and Prasadarao, 2008). The fact that macrophage apoptosis 
might also benefit the host is supported by the observation 
that many bacteria have evolved mechanisms to facilitate 
survival within macrophages (Sansonetti, 2001). Our studies 
demonstrate that E. coli enters macrophages by increasing the 
expression of FcRI and TLR2 (Mittal et al., 2010) and 
multiply, indicating that E. coli utilizes several strategies for 
survival  during  the  progression  of  infection  that  results   
in meningitis.
Although the neonatal inflammatory response is con-
sidered intrinsically hyporesponsive, the clinical observa-
tion is that neonates more often develop a severe systemic 
inflammatory response syndrome (SIRS) during sepsis than 
children and adults (Pillay et al., 1994; Schultz, et al., 2002). 
Pathophysiological events of sepsis suggest that proinflam-
matory molecules that initiate SIRS trigger the release of 
antiinflammatory molecules to limit inflammation (Bone 
et al., 1997). The antiinflammatory response, which is pri-
marily mediated by IL-10 and TGF-, is referred to as the 
compensatory antiinflammatory response syndrome (CARS; 
Powell, 2000). Therefore, an imbalance between SIRS and 
CARS is responsible for the exaggerated inflammatory response 
in neonates, and thus, for the high morbidity and mortality 
of preterm infants during infection (Duggan et al., 2001; 
Schultz et al., 2004). However, the role of IL-10 in E. coli 
infection is virtually unknown. In this study, a well-estab-
lished newborn mouse model of meningitis using WT and 
IL-10/ mice was used to determine the role of IL-10 in 
the pathogenesis of meningitis by E. coli K1. Furthermore, we 
examined the effect of IL-10 administration on the progression 
and resolution of infection.JEM VOL. 207, June 7, 2010 
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immunopathology (Fig. 2 C). Similarly, 
IL-10/  animals  were  also  rescued 
from E. coli infection by rh-IL-10 ad-
ministration at 12 h after infection (unpublished data). De-
spite the survival of E. coli K1–infected infants as a result of 
antibiotic treatment, the neurological sequelae impose long-
lasting effects on the quality of their life (Shah et al., 2005; 
Karageorgopoulos et al., 2009). In addition, the number of 
E. coli K1 strains that are resistant to third generation anti-
biotics is on the rise, and therefore the morbidity and mor-
tality rates might increase considerably (Ramdani-Bouguessa 
et al., 2006; Boyer-Mariotte et al., 2008; Dubois et al., 2009). 
Therefore, to examine whether rh-IL-10 administration also 
prevents antibiotic-resistant E. coli infection, newborn mice 
were infected with cefotaxime-resistant or sensitive strains of 
E. coli K1 (E. coli CTXR or E. coli CTXS) and treated with 
cefotaxime starting at 48 h after infection (10 mg/kg body 
weight). The antibiotic therapy failed to rescue the E. coli 
CTXR–infected animals treated with cefotaxime, and all the 
mice succumbed to infection by 96 h after infection, whereas 
animals given E. coli CTXS survived. In addition, the animals 
infected with E. coli CTXR and treated with cefotaxime still 
showed high levels of bacteremia and CSF cultures were 
positive for meningitis, whereas animals with E. coli CTXS 
IL-10 was down-regulated during the chronic phase of E. coli 
K1 infection.
Administration of IL-10 during high-grade bacteremia 
improves the outcome of E. coli K1 meningitis
To  examine  whether  the  administration  of  IL-10  would 
protect these animals, a single dose of various concentrations 
of recombinant human IL-10 (rh-IL-10) or PBS was injected 
intraperitoneally into mice at 48 h after infection. Doses of 
0.1 µg and 1.0 µg per animal did not show a significant dif-
ference in the bacterial load compared with infected WT an-
imals. However, administration of 2.5 or 5 µg of rh-IL-10 
after 48 h after infection, by which time the bacteremia levels 
were already high, rescued the animals from infection by 75 
and  100%,  respectively  (unpublished  data).  The  bacterial 
count and inflammatory response in rh-IL-10–treated (5 µg) 
animals was reduced to basal levels in blood, and the animals 
appeared normal by 6 d after infection (Fig. 2, A and B). This 
rescue by rh-IL-10 also prevented, and probably reversed, 
the macrophage and PMN infiltration into the brain, and 
thus resolved the inflammation and significantly reduced the 
Figure 1.  Cytokine production, pathogen 
load, and brain histopathology in E. coli 
K1–infected mice. WT and IL-10/ mice at 
day 3 were infected intranasally with 103 CFU 
of E. coli K1, and the production of cytokines 
was examined by ELISA. The peak production 
of IL-10 was observed at 12 h after infection 
in WT mice (A). IL-10/ animals showed 
higher production of serum TNF and blood 
bacterial load compared with WT mice  
(B and C). H&E staining of the brain sections 
revealed greater infiltration of neutrophils 
and apoptosis of neurons in the hippocampus 
in brains of infected mice compared with 
control uninfected mice. Significant damage 
to leptomeninges and hemorrhage in white 
matter was also observed (D). These patho-
logical changes were much more pronounced 
and severe in IL-10/ mice. Yellow arrows 
indicate neutrophil infiltration and white 
arrows indicate the apoptosis of neurons. Half 
of the infected brains from WT and IL-10/ 
mice were homogenized and subjected to 
flow cytometry. IL-10/ animals infected 
with E. coli succumbed to infection by 24 h, 
therefore the data are shown up to 24 h.  
Microglia, B cells, granulocytes, and macro-
phages were significantly increased in IL-10/ 
mice compared with WT mice (E-H). The results 
were obtained from six independent experi-
ments with 12 animals per group. Data repre-
sent mean ± SEM. *, P < 0.001 by two-tailed 
Student’s t test. Bars, 10 µm.1310 IL-10 administration prevents neonatal meningitis | Mittal et al.
(unpublished data). These results dem-
onstrate that administration of exoge-
nous  IL-10  protects  newborn  mice 
from  brain  damage  and  the  occur-
rence of meningitis by controlling proinflammatory cyto-
kines and by enhancing the clearance of E. coli K1 during 
later stages of infection.
E. coli K1 infection causes damage to the brain similar  
to that of in humans
Although the histology of infected brains of rodents have 
been compared in some studies (Glode et al., 1977; Ballok et al., 
2004), which showed similar neuronal damage to that of 
human brains, the differences in the morphology of the whole 
brains have not established. Therefore, to examine whether 
the gross morphological changes of infected mouse brain are 
similar to that of human brain in E. coli infection, virtual his-
tology (micro-CT) of the brains of infected mice was per-
formed. Magnetic resonance images (MRIs) of a neonate 
with E. coli K1 meningitis admitted to CHLA were also exam-
ined and compared (Fig. 3, B and C, and Videos 1 and 2). In 
both mice and the neonate, we observed hydrocephalus, gray 
demonstrated declining bacteria levels over the time (Fig. 2, 
D and E). In contrast, the animals infected with E. coli CTXR 
and treated with rh-IL-10 (5 µg/animal) survived well and 
showed no signs of bacteremia and the occurrence of menin-
gitis found in mice with E. coli CTXS infection (Fig. 2, D and E). 
To test whether cefotaxime treatment of newborn mice 
reveals normal brain histology, pathological examination of 
brain tissues from animals infected with E. coli CTXR and 
CTXS was performed. A significant loss of neuronal cells was 
observed, supporting the notion that antibiotics cannot re-
store normalcy in the brain (Fig. 3 A). This indicates that the 
neurological sequelae in infants, despite treatment with anti-
biotics, could be caused by the residual damage to the brain. 
In contrast, the histopathology of the brains obtained from 
mice infected with E. coli CTXR and treated with rh-IL-10 
showed no signs of damage (Fig. S2 F). Notably, injection 
of 1 µg of rh-IL-10 along with cefotaxime restored the 
morphology of brain and other organs to normal condition 
Figure 2.  Administration of exogenous 
rh-IL-10 decreases bacteremia and the 
occurrence of meningitis in newborn mice 
induced by E. coli K1. (A) Infant mice were 
infected with 103 CFU of E. coli and, after 48 h, 
5 µg of rh-IL-10 in 10 µl of saline was ad-
ministered for each animal. Blood was col-
lected at various time points, and the levels of 
bacteremia were determined by plating the 
dilutions on blood agar containing antibiotics. 
Infected and untreated mice were sacrificed 
at 72 h after infection for ethical reasons.  
(B) Various cytokines measured in the rh-IL-10–
administered animals demonstrated that the 
levels of proinflammatory cytokines reduced 
to basal levels. (C) Histological examination of 
brain sections revealed normal morphology of 
the brain comparable to control uninfected 
mice without any infiltration of neutrophils 
and apoptosis of neurons in the hippocampus 
in rh-IL-10–treated animals. (D) Some groups 
of animals were infected with cefotaxime-
resistant E. coli (E. coli CTXR) or cefotaxime-
sensitive E. coli (E. coli CTXS). At 48 h after 
infection, infected mice were treated with 
cefotaxime or rh-IL-10, blood was collected 
and enumerated by plating on antibiotic con-
taining agar. (E) CSF samples were collected 
from all animals either at 72 or 168 h after 
infection and cultured in broth containing 
appropriate antibiotics. The data are repre-
sentative of 6 independent experiments with 
12 animals in each group. Data represent  
mean ± SEM. *, P < 0.001 by two-tailed  
Student’s t test. Bars, 20 µm.JEM VOL. 207, June 7, 2010 
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macrophages provide protection at the site of in-
fection and are the primary source of inflammatory 
cytokines. Therefore, we examined the produc-
tion of TNF production in neutrophils and mac-
rophages infected with E. coli K1 in vitro at various 
time points and also the efficacy of anti-TNF anti-
body to neutralize the produced cytokine. The un-
treated or isotype-matched control antibody-treated 
neutrophils or macrophages infected with E. coli 
produced TNF in detectable levels at 2 h after in-
fection and increased 8-fold at 6 h after infection 
(Fig. 4 A and Fig. S3 A). Preincubation of the 
phagocytes  with  anti-TNF  antibody  completely 
neutralized the TNF production. The survival of 
E. coli K1 in anti-TNF antibody pretreated neu-
trophils or macrophages was not affected although 
the bacteria were completely taken up by the cells by 6 h after 
infection (Fig. 4, B and C, and Fig. S3, B and C). In addi-
tion, anti-TNF antibody failed to rescue the neutrophils or 
macrophages from E. coli K1–mediated apoptosis (Fig. 4 D 
and Fig. S3 D). To examine the effect of anti-TNF antibody 
in vivo, infected animals were treated with anti-TNF anti-
body at 48 h after infection. Mice infected with E. coli with or 
without administration of control antibody showed a gradual 
increase in TNF production in both blood and brain, whereas 
administration of anti-TNF antibody neutralized the produc-
tion of the cytokine by 72 h after infection, and hence was 
not detectable by ELISA (Fig. 5, A and B). However, the 
bacterial load and the occurrence of meningitis in anti-TNF 
antibody–treated animals were similar to that of untreated or 
control antibody-treated mice (log10 8.0 ± 0.5 CFU of E. coli 
in the blood and with 90% positive CSF cultures at 72 h after 
infection; Fig. 5, C and D). Histological examination of the 
brain sections from anti-TNF antibody–treated animals exhib-
ited similar damage to the brain compared with control anti-
body or untreated animals (Fig. 5 E). These findings suggest 
that neutralizing the production of TNF does not confer pro-
tection against E. coli K1 meningitis unlike the administration 
of rh-IL-10.
matter, and white matter volume loss and dilatation of the 
lateral ventricles. These results indicate that in newborn mice 
and humans, E. coli K1 meningitis caused significant brain 
damage. Brains of infected and antibiotic-treated animals still 
showed significant edema (Video 3). However, no such brain 
damage was visible in rh-IL-10–treated animals (Video 4). 
Furthermore, volumetric analysis of infected brains demon-
strated a significant loss of a portion of the forebrain in mice 
upon infection, which was prevented by rh-IL-10 treatment 
(Fig. 3 C and Videos 5–7).
Anti-TNF antibody pretreatment did not  
prevent the occurrence of E. coli K1 meningitis  
in newborn mice
The production of high amounts of proinflammatory cyto-
kines, especially TNF in mice infected with E. coli K1, might 
be responsible for the exacerbated pathophysiology and or-
gan dysfunction observed in these animals. Because the ad-
ministration of rh-IL-10 reduced proinflammatory cytokines 
at one end of the treatment regimen and cleared the patho-
gen on the other end, it is reasonable to speculate that sup-
pressing the overproduction of TNF may also produce 
protective effects similar to that of rh-IL-10. Neutrophils and 
Figure 3.  Histopathology and micro-CT of brains from 
mice, and MRIs of a human neonate infected with  
E. coli. (A) H&E staining of brain sections from animals in-
fected with E. coli CTXS or CTXR followed by antibiotic treat-
ment demonstrate that E. coli CTXS–induced pathology still 
remained. Yellow arrows indicate neutrophil infiltration and 
white arrows indicate the apoptosis of neurons. (B) MRIs  
of a neonate with E. coli K1 meningitis admitted to CHLA and 
micro-CT images of infant mice infected with E. coli K1.  
(C) Saggital sections of newborn mice treated with rh-IL-10 
or cefotaxime and total volume pictures of brains of infant 
mice uninfected and infected with bacteria. The arrows indi-
cate dilation of ventricles and loss of neurons. Three inde-
pendent experiments were performed with 10 mice per 
group for histopathology experiments. Two animals per 
group were used for micro-CT studies. Bars, 10 µm.1312 IL-10 administration prevents neonatal meningitis | Mittal et al.
or by modulating their entry into the cells, such that the nor-
mal phagocytic arsenal is circumvented. To test the latter 
hypothesis, we examined the expression of surface pathogen 
associated recognition receptors on neutrophils isolated from 
mice infected with E. coli K1. Flow cytometry analysis re-
vealed increased expression of TLR2 and FcRI (CD64), but 
reduced expression of TLR4 and CR3 (Fig. 6 E). Notably, 
neutrophils from infected and rh-IL-10–treated mice showed 
significantly increased expression of CR3 and TLR4 and 
down-regulation of TLR2 and FcRI. A similar receptor 
profile was observed on human neutrophils (Fig. S4 D). In-
troducing siRNA to CR3 into neutrophils in vitro further 
substantiated the role of CR3 in the phagocytosis of E. coli 
K1 by neutrophils after rh-IL-10 treatment. E. coli entered 
and survived in neutrophils transfected with CR3-siRNA 
and pretreatment with rh-IL-10 had no effect on uptake and 
killing of the bacterium (Fig. 6, F and G). The protective ef-
fect of rh-IL-10 on the apoptosis of infected neutrophils was 
also abrogated by suppressing the expression of CR3 (Fig. 6 H). 
These data suggest that rh-IL-10 administration up-regulates 
the expression of CR3 in neutrophils leading to enhanced 
killing of E. coli K1. In addition to neutrophils, macrophages 
also play an important role in the clearance of invading 
pathogens. Therefore, we also examined the effect of rh-IL10 
on the phagocytosis of E. coli and surface expression of vari-
ous receptors upon infection in macrophages. Peritoneal macro-
phages from both WT and IL-10/ exhibited similar uptake 
and intracellular survival of E. coli, whereas rh-IL-10 treat-
ment reduced the survival of bacteria in these cells signifi-
cantly (Fig. S5, A and B). The viability and the expression of 
surface receptors were also similar to that of the expression 
observed in neutrophils (Fig. S5, C and D). In addition, no 
difference in uptake, survival, apoptosis, and receptor profile 
of CR3 knockout macrophages even after treatment with 
rh-IL-10 compared with control siRNA-treated macrophages 
was observed (Fig. S5, E–H). This indicates that rh-IL-10 
enhances CR3 expression so that the bacteria enter through 
CR3 for efficient destruction by phagocytes.
IL-10 treatment fails to protect mice that lack CR3 
expression against E. coli–induced meningitis
To confirm that CR3 expression is critical in vivo for 
rh-IL-10 mediated protection against E. coli infection and 
brain damage, CR3 expression in mice was suppressed 
using Invivofectamine reagent. Groups of animals were 
transfected with premixed control siRNA or CR3-siRNA 
and Invivofectamine reagent by intraperitoneal injection. 
CR3 expression in neutrophils, peritoneal macrophages, 
liver, and spleen was then examined by flow cytometry. 
The expression of CR3 was completely absent in neutro-
phils, macrophages, and other tissues of transfected mice 
(Fig. 7 A and not depicted). Determination of bacterial 
load in the blood of CR3-siRNA–transfected and –infected 
animals showed that E. coli entered the blood within 2 h 
and multiplied to a log10 CFU of >5 by 24 h similar to that 
of control siRNA transfected mice (Fig. 7 B). Administration   
IL-10 treatment increases neutrophil and macrophage 
phagocytosis of E. coli by up-regulation of CR3 expression
The ability of rh-IL-10 treatment to clear the pathogen from 
the circulation of infected mice suggests increased phagocy-
tosis of the bacteria by neutrophils and/or macrophages prob-
ably mediated by IL-10R. Therefore, we examined whether 
IL-10R1 is expressed in uninfected mouse neutrophils by 
flow cytometry. The data revealed that IL-10R1 expressed in 
good quantity on the surface of neutrophils (Fig. 6 A). Fur-
thermore, the effect of rh-IL-10 treatment of neutrophils be-
fore bacterial infection on the phagocytic activity of neutrophils 
isolated from WT animals was examined ex vivo. E. coli K1 
enters and survives in neutrophils isolated from WT mice; 
however, neutrophils pretreated with rh-IL-10 showed en-
hanced uptake of E. coli K1 and killing of bacteria within 6 h 
after infection (Fig. 6, B and C). Neutrophils from WT mice 
infected with E. coli K1 underwent rapid apoptosis compared 
with cells from rh-IL-10–treated animals (Fig. 6 D). Neutro-
phils from IL-10/ mice showed no capacity to kill the bac-
teria and underwent apoptosis very rapidly ex vivo. They 
could, however, be rescued from E. coli–induced apoptosis 
with rh-IL-10 pretreatment. Similar results were observed 
with neutrophils isolated from human peripheral blood 
(Fig. S4, A–C). Collectively, these data indicate that bacteria 
might prevent bactericidal events in neutrophils either by 
suppressing the apoptotic mechanisms once inside neutrophils 
Figure 4.  Effect of Anti-TNF antibody treatment on phagocytosis 
of E. coli by neutrophils: Neutrophils were isolated from the blood of 
mice pretreated with anti-TNF antibody, isotype matched control anti-
body, or left untreated and infected with E. coli. The production of TNF 
was assessed at different infection times by ELISA (A). The uptake (B) and 
intracellular bacteria (C) were also determined after infecting the cells at 
a multiplicity of infection of 10 (cell to bacteria ratio, 1:10). The viability 
of neutrophils was examined by Annexin V and propidium iodide staining 
(D). Data represent mean ± SEM and are representative of three indepen-
dent experiments performed in triplicate. *, P < 0.001 by two-tailed  
Student’s t test.JEM VOL. 207, June 7, 2010 
Article
1313
IL-10–induced suppression of 
prostaglandin E-2 (PGE-2) is responsible 
for enhanced expression of CR3  
and bactericidal activity of neutrophils 
and macrophages
Two important mediators of inflamma-
tory response during bacterial meningitis 
are nitric oxide and PGE-2 (Kim, 2003). 
Although there is limited information on 
the role of prostanoids, such as PGE-2 in 
meningitis, one clinical study showed 
that 72 of 80 infants and children with meningitis exhibited 
elevated levels of CSF PGE-2 (Mustafa et al., 1990). Notably, 
PGE-2 has also been involved in down-regulation of CR3 
expression in monocytes and macrophages (Zeidler et al., 
2000). Therefore, to examine whether PGE-2 is responsible 
for rh-IL-10–induced protection against meningitis caused 
by E. coli, the production of PGE-2 in neutrophils and macro-
phages was examined. Neutrophils infected with the bacteria 
showed significantly greater production of PGE-2 over the 
time in comparison to uninfected cells, which levels were re-
duced by >80% by rh-IL-10 treatment (Fig. 8 A). In contrast, 
E. coli–infected neutrophils in which PGE-2 expression is sup-
pressed by introducing siRNA to PGE synthase 2 (PGES-2) 
demonstrated no production of PGE-2 in comparison to con-
trol siRNA-transfected cells (Fig. 8 B). The PGES-2 siRNA–
transfected neutrophils, despite engulfing the bacteria in a 
manner similar to that of control siRNA/neutrophils, killed 
very efficiently and no detectable bacteria were observed 
by 6 h after infection (Fig. 8, C and D). In contrast, intra-
cellular E. coli in control siRNA/neutrophils survived and 
of  rh-IL-10  in  control  siRNA  transfected  animals  re-
duced the bacterial load, whereas it had no effect on CR3 
knocked down animals. The animals showed positive CSF 
cultures and histopathological analysis revealed brain dam-
age and infiltration of neutrophils similar to that of WT 
animals infected with E. coli (Fig. 7, C and D). The pro-
tective effect of rh-IL-10 administration during high-level 
bacteremia  on  cytokine  production  in  CR3  knocked 
down mice was completely abrogated (Fig. 7 E, only TNF 
data are depicted). Neutrophils from CR3-siRNA–trans-
fected and –infected animals revealed greater expression of 
TLR2  and  FcRI  and  did  not  change  in  animals  with   
rh-IL-10 treatment (Fig. 7 F). Similar results were also ob-
served with peritoneal macrophages isolated from CR3 
knocked down mice (unpublished data). These results col-
lectively  demonstrate  that  CR3  expression  was  signifi-
cantly suppressed during the progression of the disease   
by E. coli K1 and the protective effects of rh-IL-10 are 
caused by restoration of CR3 expression in neutrophils 
and macrophages.
Figure 5.  Anti-TNF antibody administration 
fails to rescue the mice from E. coli K1 men-
ingitis. 3-d-old mice were infected with E. coli 
and, after 48 h, 5 µg of anti-TNF antibody in 10 µl 
of saline was administered for each animal. The 
production of TNF was assessed in blood (A) and 
brain homogenates (B) of infected mice at differ-
ent times after infection by ELISA. TNF levels were 
reduced to basal levels due to anti-TNF antibody 
treatment in these animals by 72 h after infec-
tion. Blood was collected at various time points, 
and the levels of bacteremia were determined by 
plating the dilutions on blood agar containing 
antibiotics (C). CSF samples were collected from 
all animals at 72 h after infection and cultured in 
broth containing appropriate antibiotics (D). 
Brains were harvested from infected and unin-
fected mice, and the brain sections were sub-
jected to H&E staining (E). Yellow arrows indicate 
neutrophil infiltration and white arrows indicate 
the apoptosis of neurons. The results were ob-
tained from three independent experiments with 
12 animals per group. Data represent mean ± 
SEM. *, P < 0.001 by two-tailed Student’s t test. 
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biotic-resistant E. coli further complicates treatment options 
(Dubois et al., 2009), warranting the necessity of new treat-
ments that control both bacterial load and inflammatory re-
sponse. Our findings provide novel insights into the role of 
IL-10 in the control of pathogen load at times of high-grade 
bacteremia in a newborn mouse model of E. coli meningitis. 
Although we expected that exogenous administration of 
IL-10 would decrease disease severity because of suppression 
of the proinflammatory response, its effect in the control of 
pathogen load was most surprising. In the majority of situa-
tions, IL-10 has a suppressive effect on both macrophages and 
dendritic cells (Moore et al., 2001; Demangel et al., 2002) 
and most of the animal models have shown that IL-10 inhib-
its antimicrobial response while protecting from immunopa-
thology (Hunter et al., 1997; Wilson et al., 2005). In contrast 
to this paradigm, IL-10 plays the opposite role in E. coli infec-
tion; it helps control the phagocytic activity of immune cells 
to clear the pathogens while reducing inflammation. Some 
studies have reported that persistent bacteremia is the result of 
loss of pathogen clearance caused by apoptosis of lympho-
cytes (Hotchkiss et al., 2001; Alileche et al., 2005; Wesche-
Soldato et al., 2007). Also, there is evidence that patients dying 
from sepsis have markedly increased lymphocyte apoptosis in 
the spleen (Toti et al., 2004; Felmet et al., 2005). Recently, 
it has been shown that IL-10 generates pathogen-clearing 
phagocytes (monocytes and macrophages), which are resistant 
to complement lysis, and thereby enabled to survive longer in 
a hostile inflammatory environment (Koch et al., 2009). Our 
findings suggest that IL-10 treatment prevents neutrophil and 
macrophage apoptosis induced by E. coli, and thereby increases 
multiplied over the same time period. Similarly, suppression 
of PGES-2 expression in neutrophils renders the cells resis-
tant to apoptosis despite infection with bacteria (Fig. 8 E). 
In  addition,  E.  coli–infected  PGES-2  siRNA/neutrophils 
showed increased expression of CR3 and TLR4 and de-
creased expression of TLR2 and FcRI, similar to expression 
levels observed in rh-IL-10–pretreated and infected neu-
trophils (Fig. 8 F). We therefore examined whether mice in-
fected with E. coli induce the production of PGE-2. On par 
with the in vitro data, the production of PGE-2 in blood in-
creased twofold by 72 h in comparison to the levels produced 
at 24 h after infection and administration of rh-IL-10 at 48 h 
after infection significantly reduced circulating PGE-2 by 
72 h (Fig. 8 G). The levels of PGE-2 in the brains of infected 
animals exhibited a similar increase. These levels decreased to 
baseline after rh-IL-10 treatment (Fig. 8 H). Similar data on 
PGE-2 production was also obtained with peritoneal macro-
phages (Fig. S6, A–F), substantiating the role of PGE-2 in 
rh-IL-10–induced protective effects during the development 
of E. coli K1 meningitis.
DISCUSSION
Currently, the primary mode of treatment of E. coli meningi-
tis is limited to antibiotics, which reduced the mortality and 
frequency of complications, but the incidence of serious neu-
rological disability remains alarmingly high (Kim, 2003). 
Trivedi et al. (2007) showed that focal anisotropy values were 
significantly greater in patients with E. coli infection after 
antibiotic treatment than in the controls, indicating that the   
inflammation is still active. Moreover, the emergence of anti-
Figure 6.  IL-10 treatment increased the phagocytosis of E. coli by neutrophils via up-regulation of CR3 expression. Neutrophils were isolated 
from the blood of WT mice and the expression of IL-10R1 was examined by flow cytometry (A). The uptake of E. coli (B) and intracellular bacteria (C) were 
then assessed after infecting the cells with E. coli at an MOI of 10. Further, the viability of the cells was examined by Annexin V and propidium iodide 
staining and analyzed by flow cytometry (D). The expression of TLR2, TLR4, CR3, and FcRI (CD64) was examined on the surface of neutrophils by flow 
cytometry after infection with E. coli K1 and graphed after subtracting the values of isotype matched controls (E). In separate experiments, neutrophils 
were transfected with control siRNA or CR3 siRNA and treated with rh-IL-10. The uptake (F), intracellular survival (G) of bacteria, and viability of neutro-
phils (H) were determined upon infection with E. coli. The experiments were performed five times in triplicate independently, and the error bars represent 
SEM. The decrease or increase in various parameters was statistically significant with rh-IL-10 treatment compared with untreated conditions. *, P < 0.01; 
**, P < 0.001; @, P < 0.04 by two-tailed Student’s t test.JEM VOL. 207, June 7, 2010 
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in transmigration of neutrophils from 
the blood to the site of inflammation, it is possible that lack 
of occurrence of meningitis in CR3 knockdown mice could 
be caused by inefficient migration of neutrophils, which may 
be acting as reservoirs for E. coli multiplication during the 
early stages of infection. However, mice deficient in CR3 
have been developed and found to have normal migration of 
neutrophils in the peritoneal cavity after chemical and TNF 
stimulus (Lu et al., 1997). LFA-1 has been shown to over-
shadow the contribution of CR3 for neutrophil migration 
and adhesion to endothelial cells, indicating that CR3 is not 
absolutely necessary (Ding et al., 1999). In agreement, histo-
pathological sections of brains of CR3 knocked down and 
infected mice also exhibited neutrophil infiltration similar 
to that of WT-infected mice, indicating neutrophil migra-
tion is not defective in CR3-suppressed mice. Furthermore, 
increased formation of PGE-2 was observed in the blood of 
E. coli–infected mice and also by neutrophils and macro-
phages ex vivo upon infection. Biogenesis of PGE-2 has been 
shown to occur through TLR2 signaling during apoptotic 
neutrophil uptake by macrophages in acute BCG infection 
(D’Avila et al., 2008). The PGE-2 production observed in E. coli 
K1 meningitis corroborates this mechanistic concept, as we also 
observed significant increase in TLR2 production in neutro-
phils and macrophages upon infection with E. coli K1.   
the phagocytosis of the bacteria. In animal models using adult 
mice, it has been shown that both Gram-negative bacteria 
and mycobacteria induced the recruitment of neutrophils, 
which  secrete  abundant  amounts  of  IL-10  (Zhang  et  al., 
2009). In acute mycobacterial infection, neutrophil-derived 
IL-10 controlled the inflammatory response of dendritic cells, 
monocytes, and macrophages in the lung (Zhang et al., 2009). 
However, diminished production of IL-10 mRNA and 
IL-10 protein in term and preterm neonates compared with 
adults was observed after stimulating with LPS (Schultz et al., 
2004). We also observed decreased IL-10 production and in-
creased  levels  of  proinflammatory  cytokines  in  blood  and 
brain of E. coli–infected neonatal mice 24 h after infection. 
Therefore,  IL-10  produced  by  neutrophils  may  not  be 
enough, and excessive IL-10 quantities may be required to 
subdue the inflammatory response and improve phagocytosis 
of pathogens by neutrophils and macrophages in neonates.
Our studies also demonstrated that the IL-10–induced 
bactericidal activity of neutrophils and macrophages is caused 
by increased expression of CR3 and TLR4, which was sup-
pressed during the infection without treatment. The role of 
CR3-mediated clearance of E. coli from the blood was 
further substantiated in mice by suppressing CR3 expression 
using siRNA and Invivofectamine. Because CR3 plays a role 
Figure 7.  The protective effect of rh-IL-10 
is abrogated in CR3 knockdown mice. 
Newborn mice were injected with CR3 siRNA 
in Invivofectamine reagent to knockdown the 
expression of CR3, as described in Materials 
and methods. The suppression of CR3 in neu-
trophils was evaluated by flow cytometry 
using an anti-CR3 antibody. Isotype-matched 
antibodies were also used as controls for CR3+ 
and CR3— cells (A). Mice were infected with  
E. coli K1 and the bacterial load in blood was 
examined at different times after infection 
(B). CSF samples were collected from the ani-
mals at 72 h after infection and cultured in 
broth containing appropriate antibiotics (C). 
Histopathological examination of brain sec-
tions revealed significant damage in brains of 
CR3 knockdown mice, even after treatment 
with rh-IL-10 compared with control unin-
fected mice (D). There was no significant dif-
ference in the TNF production in control, CR3 
knockdown, or CR3 knockdown and rh-IL-10–
treated mice compared with control siRNA 
transfection followed by rh-IL-10 treatment 
(E). In addition, the receptor profile of neutro-
phils was unaffected despite treatment with 
rh-IL-10 in comparison to control treatment 
(F). The results were obtained from six inde-
pendent experiments with 12 animals per 
group. Data represents mean ± SEM. *, P < 0.001 
by two tailed Student’s t test. Bars, 10 µM.1316 IL-10 administration prevents neonatal meningitis | Mittal et al.
jury are predominant: necrotic cortical injury 
and apoptotic hippocampal injury, as seen in 
E. coli–infected mice in this study (Nau et al., 
1999; Kim, 2003). Neuronal injury associated 
with bacterial meningitis probably involves 
many microbial and host factors. Adjunct ther-
apy with dexamethasone has been shown to re-
duce hearing impairment and other neurological 
sequelae in children with H. influenzae type b 
meningitis, but dexamethasone was shown to 
aggravate hippocampal injury in experimental 
models of pneumococcal meningitis (Wald et al., 
1995; Leib et al., 2003). In contrast to these 
observations, IL-10 treatment completely pre-
vented and/or restored the damaged brain as 
seen in micro-CT images and histopathology. 
Prevention  of  meningitis  after  reaching  a 
threshold level of bacteremia is a very important 
therapeutic strategy, as the diagnosis of menin-
gitis is difficult until after the bacteria reaches the central ner-
vous system. The finding of prevention of meningitis caused 
by antibiotic-resistant strains by exogenous IL-10 is significant 
to treat these patients. This function indicates that an adjunct 
therapy containing a regimen of antibiotics and small quanti-
ties of IL-10 would be possible to treat neonates. Since IL-10 
therapy has already been used in adults for some autoimmune 
diseases like psoriasis, it is possible that administration of small 
quantities of exogenous IL-10 would not have adverse effects 
on neonates (Friedrich et al., 2002). Although, the concept 
of treating neonates with E. coli infections by exogenous IL-10 
remains to be tested, these findings provide a strong ratio-
nale for exploration of IL-10 therapies beyond antibiotic treat-
ment alone. This IL-10 therapy may also form the basis of future 
therapeutic strategies to treat meningitis.
IL-10 administration suppressed the formation of PGE-2 by 
neutrophils and macrophages, in which case the expression of 
TLR2 in these cells suppressed and induced the expression of 
CR3. It has been demonstrated that IL-10 inhibits the produc-
tion of PGE-2 induced by LPS in monocytes (Niiro et al., 
1994); however, PGE-2 generated during efferocytosis en-
hanced the production of IL-10 (Medeiros et al., 2009). Thus, 
the relationship between IL-10 and PGE-2 may be depen-
dent on the biological phenomena that are taking place or the 
presence of other pro- and antiinflammatory cytokines in the 
milieu. Collectively, these results suggest that E. coli entry via 
receptors other than CR3 target PGE-2 to enhance bacterial 
survival and replication in host cells.
Studies in experimental animals and humans with bacte-
rial meningitis have shown that two forms of neuronal in-
Figure 8.  E. coli K1 induces the production of 
PGE-2 in vitro and in vivo. Neutrophils isolated from 
the blood of WT mice were infected with E. coli ex vivo 
and the production of PGE-2 was determined by EIA (A). 
Neutrophils, when transfected with PGES-2 siRNA, sig-
nificantly reduced the production of PGE-2 compared 
with control siRNA-transfected cells (B). Assessment of 
the uptake (C), intracellular bacteria (D), and viability of 
neutrophils (E) demonstrated that lack of PGE-2 produc-
tion enhanced phagocytosis and prevented apoptosis of 
neutrophils, although the uptake was not affected. The 
receptor profile of PGES-2 or control siRNA transfected 
neutrophils infected with E. coli in vitro was examined by 
flow cytometry (F). In addition, the production of PGE-2 
was examined in blood (G) and brain homogenates (H)  
of E. coli–infected mice with or without rh-IL-10. The  
ex vivo studies were performed three times independently 
in triplicate, whereas data from in vivo studies were ob-
tained from six independent experiments with 12 ani-
mals for each group. Data represent mean ± SEM.  
*, P < 0.001 by two-tailed Student’s t test.JEM VOL. 207, June 7, 2010 
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RT-PCR. For detection of IL-10 by RT-PCR, RNA was isolated from 
the brains of uninfected and infected mice with TRIZOL-LS-reagent 
(Invitrogen). RNA was quantified using a NanoDrop machine. RT-PCR 
was performed using the following primer sequences: sense, 5-ACCTGG-
TAGAAGTGATGCCCCAGGCA-3; antisense, 5-CTATGCAGTTGAT-
GAAGATGTACCA-3. Mouse GAPDH was used as an internal control, 
using  the  following  primer  sequences:  sense,  5-CATCACCATCTTC-
CAGGAGCG-3; antisense, 5-GAGGGGCCATCCACAGTCTTC-3. Neg-
ative controls without RT were performed in parallel for every reaction, to 
exclude amplification of contaminating DNA. The amplified products were 
separated on a 1% agarose gel and were stained with ethidium bromide. The 
gels were photographed, and optical densities were determined by using a 
computer imaging analysis system (Visitron Systems GmbH). RT-PCR was 
performed three times and the mean density of PCR products was deter-
mined to calculate the ratio of IL-10 to GAPDH mRNA.
Mouse brain micro-CT imaging (virtual histology). Formalin-fixed 
specimens were sent to Numira Biosciences for micro-CT imaging. Speci-
mens were stained with a proprietary contrast agent. A high-resolution, vol-
umetric micro-CT scanner (CT40; ScanCo Medical) was used to scan the 
tissue with the following parameters: 10 µm isometric voxel resolution at 
200 ms exposure time, 2,000 views, and 10 frames per view. The micro-CT 
generated DICOM files were converted into a file format compatible with 
the image processing software applications. Using Teem (Version 1.10.0; 
http://teem.sourceforge.net/), SCIRun (Scientific and Computing Imaging 
Institute, University of Utah, Salt Lake City, Utah), and Numira’s proprie-
tary software tools, images of the samples were generated.
Phagocytosis and analysis of surface receptors. Neutrophils were iso-
lated from the peripheral blood of the human volunteers and mice as de-
scribed previously (Criss and Seifert, 2008; Luo and Dorf, 2001). IRB of 
CHLA approved the blood withdrawal protocol from human volunteers. 
Macrophages were isolated from the peritoneal cavity of mice as previously 
described (Mittal et al., 2009a). In some experiments, neutrophils and mac-
rophages  were  transfected  with  CR3  siRNA  (Invitrogen;  Oligo  ID 
MSS205544), PGES-2 siRNA (Ambion; Oligo ID 97139), or respective 
control  siRNA  using  Lipofectamine  2000+  (Invitrogen)  transfecting  re-
agent. Phagocytosis of bacteria by neutrophils and macrophages was deter-
mined by gentamicin protection assays (Mittal and Prasadarao, 2008). The 
expression of TLR2, TLR4, CR3, and FcRI on the surface of neutrophils 
and macrophages isolated from infected mice was determined by flow 
cytometry after staining with respective antibodies coupled to various 
fluorochromes, and at least 10,000 events were collected for analysis. Neu-
trophils and macrophages were gated using GR-1 and F4/80 staining, 
respectively, as well as forward and side scatter parameters. Results are 
expressed as mean fluorescence intensity subtracted from isotype-matched and 
respective uninfected controls.
Suppression of CR3 expression using Invivofectamine reagent. To 
suppress CR3 expression, newborn mice at day 1 were injected with CR3 
siRNA or control siRNA in Invivofectamine reagent (premixed in 1:1 ratio, 
10 nmol in 10 µl; Invitrogen). Invivofectamine is a proprietary lipid-based 
nontoxic transfection reagent for in vivo RNAi applications. This reagent 
stabilizes siRNA in vivo and knocks down the expression of gene of interest. 
Mice were given four doses of CR3 siRNA intraperitoneally; two doses 
before infection, one dose immediately after administration of bacteria, and 
final dose 24 h after infection.
Statistical  analysis.  For  statistical  analysis  of  data,  analysis  of  variance, 
Fischer test, Wilcoxon signed rank test, 2 test, and Student’s t test were 
applied. P values <0.05 were considered statistically significant.
Online supplemental material. Fig. S1 shows cytokine production and tis-
sue damage markers in E. coli–infected WT and IL-10/ mice. Fig. S2 shows 
CD4+ and CD8+ T cell responses, IL-10 production, and brain pathology 
MATERIALS AND METHODS
Animals. Breeding pairs of C57BL/6 IL-10/ mice and C57BL/6 WT 
mice were obtained from The Jackson Laboratory.
Infectious organisms. E. coli K1 is a rifampicin-resistant mutant of E. coli 
K1 strain RS 218 (serotype O18:K1:H7) and is sensitive to cefotaxime 
(CTXS; Prasadarao et al., 1996). Cefotaxime-resistant strain of E. coli (CTXR) 
was isolated from CSF of a newborn as previously described (Dubois et al., 
2009). Bacteria were grown in brain heart infusion broth (Difco Laborato-
ries) with appropriate antibiotics.
Newborn mouse model of meningitis. The animal studies were ap-
proved by the institutional animal care and use committee of the Saban 
Research Institute at CHLA and followed National Institutes of Health 
guidelines for the performance of animal experiments. 3-d-old mice were 
randomly divided into various groups and infected intranasally with 103 
CFU/10 µl of bacteria. Control mice received pyrogen-free saline through 
the same route. Blood was collected from the tail or facial vein at different 
times after infection and plated on LB agar containing rifampicin. CSF sam-
ples were collected aseptically under anesthesia by cisternal puncture and di-
rectly inoculated into broth containing antibiotics in which the growth of   
E. coli was considered positive for meningitis. Mice were perfused intracardi-
ally with 0.9% saline to remove blood and contaminating intravascular leu-
kocytes. Various tissues were aseptically harvested and homogenized in 
sterile PBS, and the bacterial counts were determined by plating 10-fold se-
rial dilutions on rifampicin LB agar plates.
IL-10  and  anti-TNF  antibody  treatment.  To  assess  the  effect  of   
rh-IL-10 on meningitis, groups of 3-d-old mice were infected with E. coli 
CTXS or E. coli CTXR and treated intraperitoneally at 48 h after infection 
with various doses of rh-IL-10 (0.1–5 µg/animal; (PeproTech), with cefo-
taxime (10 mg/kg body weight) or with cefotaxime and rh-IL-10 (1 µg/
animal) together. For anti-TNF antibody treatment, groups of 3-d-old mice 
were infected with E. coli CTXS and treated intraperitoneally at 48 h after 
infection with one dose of 5 µg/animal of murine anti-TNF antibody or 
isotype-matched control antibody (R&D Systems).
Histopathology. Half of the tissue samples were fixed in 10% buffered for-
malin, routinely processed, and embedded in paraffin. 4–5-µm-thick sections 
were cut using a Leica microtome and stained with hematoxylin and eosin 
(H&E; Mittal et al., 2009b).
Determination of cytokine and PGE-2 levels. The levels of TNF, IL-1, 
IL-6, IL-10, IL-12p70, and IFN-, were measured in blood and brain 
homogenates of infant mice infected with E. coli using ELISA kits from Bio-
source according to the manufacturer’s instructions. PGE-2 levels were de-
termined by EIA kit (Cayman Chemicals).
Quantitative assessment and phenotypic characterization of brain 
leukocytes. Characterization of leukocytes derived from brains of newborn 
mice was done using flow cytometry as described previously (Mittal and 
Prasadarao, 2008) using various antibodies obtained from eBioscience. Mu-
rine microglia and macrophages were identified by staining with anti-CD45 
(LAC)-biotin and anti-F4/80-FITC, respectively followed by avidin-PE/
Cy5. Inflammatory leukocytes recruited to the brain are CD45high F4/80, 
macrophages are CD45high F4/80+, and microglia are CD45low F4/80+. 
CD4+ and CD8+ T lymphocytes were stained with rat anti–mouse-CD4 
followed by goat anti–rat-phycoerythrin and anti-CD8-FITC. B lym-
phocytes were detected by staining with anti-CD45R (B220)-FITC and 
anti-CD45 (LCA)-biotin followed by avidin-phycoerythrin/Cy5. Granulo-
cytes were stained with anti-Ly6-G (GR-1), followed by goat anti–rat-PE 
and F4/80-FITC. Granulocytes were defined as Ly6-G+ F4/80. Control 
staining included incubation of brain-derived leukocytes with unlabeled or 
fluorochrome-labeled isotype-matched control antibodies. Flow cytometry 
was performed on a FACScan instrument (BD) and the data were analyzed 
with CellQuest Software.1318 IL-10 administration prevents neonatal meningitis | Mittal et al.
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